Detection of single amyloid β-protein aggregates in the cerebrospinal fluid of Alzheirner's patients by fluorescence correlation spectroscopy

Nature Medicine

Volumn 4, Issue 7, 1998, Pages 832-834

  Pitschke, M ^a   Prior, R ^a   Haupt, M ^a   Riesner, D ^a  

^a HEINRICH HEINE UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

AMYLOID BETA PROTEIN;

ADULT; AGED; ALZHEIMER DISEASE; ARTICLE; AUTOPSY; BRAIN BIOPSY; CLINICAL ARTICLE; HISTOPATHOLOGY; HUMAN; NEUROFIBRILLARY TANGLE; PRIORITY JOURNAL; PROTEIN AGGREGATION; PROTEIN DETERMINATION; SPECTROFLUOROMETRY;

AGED; AGED, 80 AND OVER; ALZHEIMER DISEASE; AMYLOID BETA-PROTEIN; HUMANS; MIDDLE AGED; PEPTIDE FRAGMENTS; SPECTROMETRY, FLUORESCENCE;

EID: 0031871740     PISSN: 10788956     EISSN: None     Source Type: Journal    
DOI: 10.1038/nm0798-832     Document Type: Article

References (19)

1. Beyreuther, K. et al. Regulation and expression of the Alzheimer's beta/A4 amyloid protein precursor in health, disease, and Down's syndrome. Ann. NY Acad. Sci. 695, 91-102 (1993).
2. Selkoe, D.J. Cell biology of the amyloid beta-protein precursor and the mechanism of Alzheimer's disease. Annu. Rev. Cell. Biol. 10, 373-403 (1994).
3. Sisodia, S.S. & Price, D.L. Role of the beta-amyloid protein in Alzheimers's disease. FASEB J. 9, 366-370 (1995).
4. Harper, J.D. & Lansbury, P.T.Jr. Models of amyloid seeding in Alzheimer's disease and scrapie: mechanistic truths and physiological consequences of the time-dependent solubility of amyloid proteins. Annu. Rev. Biochem. 66, 385-407 (1997).
5. Seubert, P. et al. Isolation and quantification of soluble Alzheimer's beta-peptide from biological fluids. Nature 359, 325-327 (1992).
6. Vigo-Pelfrey, C., Lee, D., Keim, P., Lieberburg, I. & Schenk, D.B. Characterization of beta-amyloid peptide from human cerebrospinal fluid. J. Neurochem. 61, 1965-1968 (1993).
7. Prusiner, S.B. Prion diseases and the BSE crisis. Science 278, 245-251 (1997).
8. Eigen, M. & Rigler, R. Sorting single molecules: application to diagnostics and evolutionary biotechnology. Proc. Natl. Acad. Sci USA 91, 5740-5747 (1994).
9. Hilbich, C., Kisters-Woike, B., Reed, J., Masters, C.L. & Beyreuther, K. Aggregation and secondary structure of synthetic amyloid beta A4 peptides of Alzheimer's disease. J. Mol. Biol. 218, 149-163 (1991).
10. Terzi, E., Holzemann, G. & Seelig, J. Self-association of beta-amyloid peptide (1-40) in solution and binding to lipid membranes. J. Mol. Biol. 252, 633-642 (1995).
11. Tomski, J. & Murphy, R.M. Kinetics of aggregation of synthetic beta-amyloid peptide. Arch. Biochem. Biophys. 294, 630-638 (1992).
12. Lorenzo, A. & Yankner, B.A. Beta-amyloid neurotoxicity requires fibril formation and is inhibited by congo red. Proc. Natl. Acad. Sci. USA 91, 12243-12247 (1994).
13. Bush, A.I. et al. Rapid induction of Alzheimer A beta amyloid formation by zinc. Science 265, 1464-1467 (1994).
14. Brown, A.M. et al. Selective aggregation of endogenous beta-amyloid peptide and soluble amyloid precursor protein in cerebrospinal fluid by zinc. J. Neurochem. 69, 1204-1212 (1997).
15. Podlisny M.B. et al. Aggregation of secreted amyloid beta-protein into sodium dodecyl sulfate-stable oligomers in cell culture. J. Biol. Chem. 270, 9564-9570 (1998)
16. Motter, R. et al. Reduction of beta-amyloid peptide42 in the cerebrospinal fluid of patients with Alzheimer's disease. Ann. Neurol. 38, 643-648 (1995).
17. Nitsch, R.M et al. Cerebrospinal fluid levels of amyloid beta-protein in Alzheimer's disease inverse correlation with severity of dementia and effect of apolipoprotein E genotype. Ann Neurol. 37, 512-518 (1995).
18. Dilling, H., Mombow, W. Schmidt, M.H. & Schulte-Markwort, E. (Eds.) WHO Internationale Klassifikation psychischer Störungen, ICD-10, Hans-Huber Verlag, 1994.
19. Reisberg, B., Ferris, S.H., De Leon, M.J. & Crook, T. The Global Deterioration Scale for assessment of primary degenerative dementia: Am. J. Psychiatr. 139, 1136-1139 (1982).